Evaluation of Knowledge Among Adolescents With Sickle Cell Disease.

Sickle Cell Disease Clinical Trial

— SEXODREP  

Official title:

Evaluation of Knowledge and Practices About Contraception, Sexuality and Transmission Among Adolescents With Sickle Cell Disease.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03235011
• Other study ID #: SEXODREP
• Status: Completed
• Start date: March 10, 2017
• Est. completion date: January 31, 2018

Study information

• Verified date: February 2019
• Source: Centre Hospitalier Intercommunal Creteil
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Evaluation of knowledge about contraception in sickle cell adolescents.

Description:

Sickle cell teenagers receive regular hospital medical care.

Adolescence is the time when the pathophysiology of the disease is re-explained and when questions around puberty (possibly delayed), sexuality and contraception are discussed.

Sickle cell disease, like any chronic disease, can have repercussion on the development and behavior of young patients.

Knowledge and understanding of young patients with sickle cell disease around these issues may be insufficient.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 99
• Est. completion date: January 31, 2018
• Est. primary completion date: January 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 14 Years to 19 Years

Eligibility

Inclusion Criteria:

• Patients with sickle cell disease followed at the CHIC

• Aged 14 to 19

• Both sexes

Exclusion Criteria:

• Neurological disorders that can impede understanding of the questionnaire.

• Refusal to participate.

• Not affiliated to social security.

Related Conditions & MeSH terms

• Anemia, Sickle Cell
• Sickle Cell Disease

Locations

Country	Name	City	State
France	Centre Hospitalier Intercommunal de Créteil	Créteil	Creteil

Sponsors (1)

Lead Sponsor	Collaborator
Adele CARLIER-GONOD

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score value of the questionnaire on general knowledge on contraception	questionnaire on general knowledge on contraception rated by 4 questions	at inclusion
Secondary	Score value of the questionnaire on specific knowledge on the transmission of the disease		at inclusion
Secondary	Score value of the questionnaire on the transmission of the disease knowledge		at inclusion
Secondary	Score value of the questionnaire on specific knowledge about the impact of sickle cell disease on the course of puberty		at inclusion
Secondary	Score value of the questionnaire onspecific knowledge about the impact of sickle cell disease on the course of sexuality		at inclusion
Secondary	age of the patient with sickle cell disease		at inclusion
Secondary	gender of the patient with sickle cell disease		at inclusion
Secondary	number of hospitalizations of the patient with sickle cell disease		at inclusion